Biotech vs. Shorts Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech vs. Shorts

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: LLCF who wrote (60)	7/28/1999 1:52:00 AM
From: aknahow	of 427

DAK, if a large pharma. sought to apply this theory they might not merge with a biotech company but rather acquire 51% or more of the stock in a biotech company that was working in areas that competed with the most important products of the large pharmas. then it would keep its' hands off the biotech, except to partner with them should the biotech still need more cash. Doubt any will do it this way. Why not? You don't get fired or lose face if your major drug company becomes an also ran but if the $200 million you provided an independent biotech is a total loss in three years, that will be seen as a failure.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next